SCHEDULE

Company

Eloxx Pharmaceuticals, Inc.

Filed

February 14, 2001

Accession Number

0000903100-01-000032

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →